Crescenzo DAlterio
Overview
Explore the profile of Crescenzo DAlterio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trotta A, Mazzarella V, Roggia M, DAniello A, Bene A, Vetrei C, et al.
Eur J Med Chem
. 2024 Sep;
279:116911.
PMID: 39348763
Macrocyclization presents a valuable strategy for enhancing the pharmacokinetic and pharmacodynamic profiles of short bioactive peptides. The exploration of various macrocyclic characteristics, such as crosslinking tethers, ring size, and orientation,...
2.
Portella L, Bertolini G, Guardascione G, Di Febbraro D, Ierano C, DAlterio C, et al.
Heliyon
. 2024 Aug;
10(15):e35524.
PMID: 39170328
Background: Circulating Tumor Cells (CTCs) represent a small, heterogeneous population that comprise the minority of cells able to develop metastasis. To trap and characterize CTCs with metastatic attitude, a CXCL12-loaded...
3.
Santagata S, Trotta A, DAlterio C, Napolitano M, Rea G, Di Napoli M, et al.
Clin Cancer Res
. 2024 Aug;
30(20):4755-4767.
PMID: 39167621
Purpose: To identify predictive factors of nivolumab sensitivity, peripheral blood NKs and regulatory T-cell (Treg) were evaluated in patients with metastatic renal cell carcinoma (mRCC) enrolled in the REVOLUTION trial....
4.
Trotta A, Tomassi S, Di Maiolo G, Ierano C, Vetrei C, DAlterio C, et al.
Eur J Med Chem
. 2024 Jul;
276:116669.
PMID: 39053189
The present study describes a small library of peptides derived from a potent and selective CXCR4 antagonist (3), wherein the native disulfide bond is replaced using a side-chain to tail...
5.
Santagata S, Rea G, Bello A, Capiluongo A, Napolitano M, Desicato S, et al.
Br J Cancer
. 2024 May;
130(12):2016-2026.
PMID: 38704478
Background: Tregs trafficking is controlled by CXCR4. In Renal Cell Carcinoma (RCC), the effect of the new CXCR4 antagonist, R54, was explored in peripheral blood (PB)-Tregs isolated from primary RCC...
6.
Santagata S, Rea G, Castaldo D, Napolitano M, Capiluongo A, DAlterio C, et al.
Hepatol Int
. 2023 May;
18(2):568-581.
PMID: 37142825
Background And Purpose: While HCC is an inflammation-associated cancer, CRLM develops on permissive healthy liver microenvironment. To evaluate the immune aspects of these two different environments, peripheral blood-(PB), peritumoral-(PT) and...
7.
DAlterio C, Giardino A, Scognamiglio G, Butturini G, Portella L, Guardascione G, et al.
Cells
. 2022 Nov;
11(21).
PMID: 36359736
Pancreatic ductal adenocarcinoma (PDAC) is currently the most deadly cancer. Although characterized by 5-20% of neoplastic cells in the highly fibrotic stroma, immunotherapy is not a valid option in PDAC...
8.
DAlterio C, Spina A, Arenare L, Chiodini P, Napolitano M, Galdiero F, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406620
This study investigated the prognostic role of the CXCR4-CXCL12-CXCR7 axis in advanced epithelial ovarian cancer (EOC) patients receiving first-line treatment within the MITO16A/MaNGO-OV2 phase-IV trial. CXCR4-CXCL12-CXCR7 expression was evaluated in...
9.
Ierano C, Righelli D, DAlterio C, Napolitano M, Portella L, Rea G, et al.
J Immunother Cancer
. 2022 Mar;
10(3).
PMID: 35246475
Background: Colorectal cancer (CRC) is one of the most prevalent and deadly tumors worldwide. The majority of CRC is resistant to anti-programmed cell death-1 (PD-1)-based cancer immunotherapy, with approximately 15%...
10.
Bertolini G, Cancila V, Milione M, Lo Russo G, Fortunato O, Zaffaroni N, et al.
Mol Ther
. 2021 May;
29(10):2963-2978.
PMID: 34023505
Platinum-based chemotherapy remains widely used in advanced non-small cell lung cancer (NSCLC) despite experimental evidence of its potential to induce long-term detrimental effects, including the promotion of pro-metastatic microenvironments. In...